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We previously reported Clostridium difﬁ  cile in 20% of 
retail meat in Canada, which raised concerns about poten-
tial foodborne transmissibility. Here, we studied the genetic 
diversity of C. difﬁ  cile in retail meats, using a broad Canadi-
an sampling infrastructure and 3 culture methods. We found 
6.1% prevalence and indications of possible seasonality 
(highest prevalence in winter). 
C
lostridium difﬁ  cile infection (CDI) has been associ-
ated with increased illness and death in Canada since 
2000 (1,2). Although multiple genotypes with higher levels 
of virulence and antimicrobial resistance have been recog-
nized (1,3), little is known about risk factors for CDI acqui-
sition outside healthcare facilities.
In a 2005 study, we found C. difﬁ  cile in 20% of re-
tail meats sampled in Canada (4). Limitations to that study 
included limited geographic representation, nonsystematic 
sampling, and the use of a nonvalidated culture method. 
These sampling limitations prevent valid extrapolations. 
Broader sampling and a better understanding of the culture 
methods were thus required to reassess the prevalence of 
retail meat contamination with C. difﬁ  cile. Here, we deter-
mined the prevalence of C. difﬁ  cile in retail meat by using 
a broad-based government sampling infrastructure, com-
pared 3 culture methods, characterized recovered isolates, 
and evaluated month-to-month variability in C. difﬁ  cile 
recovery.
The Study
Retail meats were obtained from 2 randomly selected 
census divisions per week from various retailers across 
Canada as part of the active retail surveillance component 
of the Canadian Integrated Program for Antimicrobial Re-
sistance Surveillance (CIPARS) (5). We tested random 
packages of ground beef as well as veal chops from milk-
fed calves; the packages were purchased by CIPARS in 
Ontario, Québec, and Saskatchewan, Canada, from January 
through August 2006. Purchased packages were sent to the 
Laboratory of Foodborne Zoonoses, Québec (ground beef), 
and to the Canadian Research Institute for Food Safety, 
Ontario (veal chops), where 35-g composite samples were 
made. Rinsates were prepared by mixing 25 g of meat and 
225 mL of buffered peptone water (placed in a stomacher 
for 15 min). Rinsates (12 mL) and the remains of the com-
posite samples (10 g) were then sent to the University of 
Guelph for C. difﬁ  cile testing. Sample size estimations in-
dicated that 211 packages were adequate to verify a preva-
lence of 20% ± 8% (α = 0.05, power = 0.8; Stata sampsi 
command [Stata Corp., College Station, TX, USA]). 
A total of 214 meat samples were cultured by using 
3 methods. One method, used in an earlier study (4), was 
tested in duplicate to assess reproducibility. All protocols 
had an enrichment phase of 7 days (Table 1), followed 
by ethanol treatment of culture sediments (96%, 1:2 [vol/
vol], 30 min), and inoculation onto solid agar for colony 
identiﬁ  cation (4,6).
Suspected colonies (swarming, nonhemolytic) were 
subcultured onto 5% sheep blood agar. C. difﬁ  cile was pre-
liminarily identiﬁ  ed with L-proline aminopeptidase activ-
ity (Pro Disc; Remel, Lenexa, KS, USA) but conﬁ  rmed by 
PCR detection of the triose phosphate isomerase gene (7).
PCR ribotyping and detection of genes for toxins A 
(tcdA), B (tcdB), binary toxin (cdtB), and toxin regulator 
(tcdC) were performed as previously described (4,8,9). Iso-
lates having either tcdA, tcdB, or cdtB were classiﬁ  ed as 
toxigenic (10).
Resulting PCR ribotypes were visually compared to 
representative PCR ribotypes previously identiﬁ  ed in cattle 
(n = 8, 2004), retail meats (n = 4, 2005), and humans (n = 
39, 2004–2006) in Ontario and Québec, Canada (2,4,11). 
The ﬁ  rst meat-derived isolate of each PCR ribotype and 1 
matching human isolate were submitted to the Centers for 
Disease Control and Prevention, Atlanta, Georgia, USA, 
for SmaI pulsed-ﬁ  eld gel electrophoresis (PFGE) and toxi-
notyping (1).
We tested selected isolates to determine the MICs of 
clindamycin, levoﬂ  oxacin, moxiﬂ  oxacin, and gatiﬂ  oxacin 
by using the Etest (AB Biodisk, Solna, Sweden) and inter-
preted the results after the isolates were incubated for 48 h 
on Brucella agar (12). Controls included C. difﬁ  cile strain 
ATCC 700057.
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Culture binary data were analyzed by using a random-
ized block design approach with a conditional logistic re-
gression analysis (SAS Institute, Cary, NC, USA) and p 
value estimations with Monte Carlo simulations. Exact 
tests for pairwise comparisons were based on LogXact 7 
and a Fortran program (Cytel Inc, Cambridge, MA, USA). 
Kappa, χ2, and Fisher exact tests were also used. Signiﬁ  -
cance was held at p<0.05.
In total, 149 ground beef and 65 veal chop samples, 
obtained from 210 retailers in Canada, were cultured for 
C. difﬁ  cile (Figure 1). The numbers of samples tested per 
month were 12, 49, 34, 5, 73, 31, 0, and 7, from January 
through August in 2006; 3 samples lacked sampling dates.
Combining the results from 4 cultures, we found the 
prevalence of C. difﬁ  cile was 6.7% (10/149) in ground 
beef and 4.6% (3/65) in veal chops from milk-fed calves. 
The combined prevalence was 6.1% (13/214). The preva-
lence of C. difﬁ  cile recovery determined by using different 
culture methods varied from 1.4% to 2.3%, but no culture 
agreement or reproducibility was observed (p>0.1). Over-
all, the individual diagnostic sensitivity of each method 
was low (<39%; Table 1).
When month-to-month variability was considered, C. 
difﬁ  cile was more commonly isolated from meat in January 
and February (11.5%, 7/61) than during the remaining 5 
months of the study (4%; 6/150; p = 0.041). This ﬁ  nding 
indicates possible seasonality, although further studies are 
needed.
A total of 28 C. difﬁ  cile isolates were cultured from 
13 meat packages (22 from ground beef; 6 from veal). 
PCR ribotyping showed 8 distinct genotypes, 7 of which 
were toxigenic and present in 10 (77%) meat packages 
(Table 2). Genotypes resembling human PCR ribotype 027/
NAP1 were found in 30.8% (n = 4) of positive samples, 
and PCR ribotypes 077/NAP2 and 014/NAP4, formerly 
reported in cattle and retail meats (3,4), were identiﬁ  ed in 
23.1% (n = 3) and 15.4% (n = 2) of samples, respectively. 
Multiple genotype contamination was also documented (2 
PCR ribotypes/sample, n = 2).
PFGE conﬁ  rmed that selected meat and human PCR 
ribotypes were identical (Figure 2). Fluoroquinolone and 
clindamycin resistance was common (41.6%–58.3%) 
among isolates tested (Figure 2).
Conclusions
In contrast to our ﬁ  rst study (4), this study evaluated 
the genetic diversity of C. difﬁ  cile in retail meats in a large 
area of Canada and tested 1–2 samples per store to prevent 
clustering. Thus, the overall prevalence observed (6.1%) 
was lower than that of previous studies in Canada (20%) 
(5) and the United States (42%) (13). Although different 
sampling and culture methods may account for the differ-
ent prevalences, taken altogether, these studies support re-
cent concerns regarding food safety.
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Table 1. Proportion of retail meat packages yielding Clostridium difficile in 4 culture replicates and estimated method sensitivity, 
Canada, 2006*† 
Culture method  % Samples with C. difficile 
Sample  Enrichment  Agar  Ground beef  Veal from milk-fed calves   Both‡ 
Culture 
sensitivity, %‡
Rinsate  TCDMNB  CDMNA  2.7 (4/149)§  0 (0/65)  1.9 (4/214)  31 
Meat¶ 
Meat¶
  TCDMNB  CDMNA  2.7 (4/149)§  1.5 (1/65)  2.3 (5/214)  39 
TCDMNB  CDMNA  1.3 (2/149)§  1.5 (1/65)  1.4 (3/214)  23 
Meat  TCCFB  Blood  1.3% (2/149)  1.5 (1/65)  1.4 (3/214)  23 
Total of contaminated packages#  6.7 (10/149)  4.6 (3/65)  6.1 (13/214)‡  100 
*Rinsate, sediment; TCDMNB, in-house C. difficile broth (CM0601; Oxoid, Basingstoke, UK) supplemented with cysteine hydrochloride, moxalactam, 
norfloxacin (CDMN, SR0173E; Oxoid), and 0.1% sodium taurocholate (Sigma-Aldrich, Inc., St. Louis, MO, USA) (4); Meat, 2 g; CDMNA, C. difficile agar 
supplemented with CDMN and 7% laked horse blood (SR0048C; Oxoid); TCCFB, broth supplemented with D-cycloserine and cefoxitin (SR0096E; Oxoid) 
and 0.1% sodium taurocholate; Blood, 5% defibrinated sheep blood. 
†Poor test agreement was found among and between cultures (ț –0.28; p>0.9). 
‡Culture sensitivity calculation based on parallel interpretation of all 4 cultures (standard comparator) and 6.1% of overall contamination. Duplicate testing 
sensitivity ranged from 46.2% (6/13) to 61.5% (8/13). 
§Represents 2 packages that simultaneously tested positive in 2 culture replicates. 
¶Protocol previously used to test meat; duplicate run (4). 
#No statistical differences were found between ground beef and veal in any culture replicate (p>0.1). 
Figure 1. Distribution of retail grocery stores sampled (n = 210) and 
proportion with contaminated meat. The overall proportion of stores 
with >1 meat package contaminated with Clostridium difﬁ  cile was 
5.7%. No statistical differences were observed when comparing the 
proportions of ground beef contamination in Québec, Ontario, and 
Saskatchewan, Canada (p>0.2). No comparisons for veal chops 
were made because Québec was the main source of this commodity; 
veal from milk-fed calves was not available in Saskatchewan, and 
only 3 stores had this type of veal during sampling in Ontario. Duplicate cultures, irrespective of method, could yield 
higher rates of C. difﬁ  cile recovery from meat. However, 
the sensitivity of duplicate testing of meat is still subopti-
mal (46.2%–61.5%) compared with the sensitivity reached 
by one of our methods (4) in human stool samples (>95%) 
(6). Suboptimal performance might be due to reduced cul-
ture selectivity and nonhomogeneous distribution or a low 
number of spores.
In addition to cross-contamination at slaughter and 
during processing, it is possible that contamination of 
muscle tissue with C. difﬁ  cile spores occurs preharvest. 
In horses, Clostridium spores have been recovered from 
muscle tissue in healthy horses (14), and a recent muscle 
sample yielded C. difﬁ  cile in a healthy cow (unpub. data). 
Translocation from the intestines and deposition of dor-
mant spores in muscle are reasonable assumptions that 
need investigation.
The increased recovery of C. difﬁ  cile from meat in 
winter suggests that a seasonal component might exist. 
This component is currently uncertain, but a possible epi-
demiologic link between this observation and the season-
ality observed in human disease (15) and the high rate of 
C. difﬁ  cile toxins in calves in winter (11) requires further 
elucidation.
The C. difﬁ  cile genotypes identiﬁ  ed in this and other 
studies (especially the NAP1 clone and PCR ribotypes 
077 and 014) (3,4,11) provide further molecular evidence 
that spore dissemination through foods should be consid-
ered. Although ingestion of spores does not necessarily 
imply infection, this study supports the potential for food-
borne transmissibility and raises questions about possible 
seasonality.
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Table 2. Molecular characteristics of 15 representative Clostridium difficile strains isolated from 13 of 214 retail meat packages tested 
in Canada, 2006* 
Type† % (no.) Toxin genes‡ tcdC deletion Toxinotype PFGE§ Product–culture Month Province
M26 23.1 (3) A
–B
–, cdtB
– NA Nontypeable Unnamed VC–C3 Feb QC
–G B – C 2 J a n O N
–G B – C 2 J u n S K
077¶ 23.1 (3) A
+B
+, cdtB
– No 0 NAP2 GB–C3 Jan QC
–G B – C 1 J a n O N
–G B – C 3 J a n Q C
J¶ 23.1 (3) A
+B
+, cdtB
+ 18 bp III NAP1 GB–C4 May ON
NAP1a GB–C4 Jun ON
– VC–C4 Feb QC
014¶ 15.4 (2) A
+B
+, cdtB
– No 0 NAP4 GB–C1 May QC
–G B – C 2 J a n Q C
C7 . 7  ( 1 ) A
+B
+, cdtB
– No – – GB–C1 Jan ON
F7 . 7  ( 1 ) A
-B
+, cdtB
– No VIII NAP9 GB–C2 Jan QC
H7 . 7 ( 1 ) A
+B
+, cdtB
- No 0 Unnamed GB – C1 Jun QC
K7 . 7 ( 1 ) A
+B
+, cdtB
+ 18 bp III NAP1-r VC–C2 Aug QC
*PFGE, pulsed-field gel electrophoresis; NA, not amplified because it lacks pathogenicity locus; VC, veal chops; GB, ground beef; C1, rinsate/TCDMNB; 
C2, meat/TCDMNB; C3, meat/TCDMNB duplicate; C4, meat/TCFFB; QC, Québec; ON, Ontario; SK, Saskatchewan; –, not performed. 
†Bidet’s PCR ribotyping method (9); 077 and 014; representative ribotypes with international nomenclatures assigned by Dr Jon Brazier, University of 
Wales, Wales, in a previous study (11). M26, non-toxigenic Canadian meat ribotype lacking pathogenicity locus (pers. com., M. Rupnik, University of 
Maribor, Slovenia) (5).
‡A, B; tcdA and tcdB genes. cdtB, binding segment of binary toxin; – and + superscripts indicate absence or presence of the gene. tcdC gene: no 
deletions (|345 bp); 18 bp, deletion type B/C (8). 
§Nomenclature at the Centers for Disease and Control and Prevention, Atlanta, GA, USA. NAP1, North America PFGE type 1. 
¶Meat PCR ribotypes matching concurrent local and international human ribotypes (2,3). Note that 28 C. difficile isolates initially identified were grouped 
into 15 strains based on molecular characteristics and source of origin; 2 meat samples simultaneously harbored 2 strains. 
Figure 2. Pulsed-ﬁ  eld gel electrophoresis (PFGE)–SmaI dendogram 
of Clostridium difﬁ  cile isolates of meat and human origin in Canada. 
Representative PCR ribotypes 077, 014, M31, and M26 are of 
meat origin from 2005 (4,11). PCR ribotype designations are 
described in Table 2. Note the genetic similarity (94.1%–100%) and 
antimicrobial resistance proﬁ  les between human and meat isolates, 
especially PCR ribotypes 014 and J. Also note the genetic similarity 
(81.8%–100%) between meat isolates from 2005 and 2006 for 
multidrug-resistant epidemic PCR ribotype 077, clindamycin-
variable, PCR ribotype 014, and nontoxigenic PCR ribotype M26. 
Resistance to all 4 antimicrobial drugs was observed in meat 
isolates of ribotypes 077 and F, which also yielded the highest level 
of clindamycin resistance (>256 μL/mL; breakpoint: >6 μL/mL). The 
breakpoints for moxiﬂ  oxacin (12) were also used for levoﬂ  oxacin 
and gatiﬂ  oxacin. R (resistant), S (susceptible), and I (intermediate) 
represent antimicrobial proﬁ  les. CDC, Centers for Disease Control 
and Prevention; NAP, North America PFGE type; NAP1-r, NAP-
related strain; Tox, toxinotyping nomenclature (M. Rupnik, Maribor, 
Slovenia); U, unnamed.Clostridium difﬁ  cile in Meat, Canada
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